These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2780331)

  • 1. [Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter].
    Klein B; Klein E; Horster FA
    Nuklearmedizin; 1989 Aug; 28(4):129-36. PubMed ID: 2780331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy for thyroid volume reduction of large goitres.
    Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
    Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases].
    Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R
    Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)].
    Mertz DP; Koch B
    MMW Munch Med Wochenschr; 1977 Jul; 119(28):945-8. PubMed ID: 408626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iodine-131 therapy for large goiter with hyperthyroidism: clinical observation of 38 cases].
    Zhao YS; Zhao CW; Huang TJ; He B; Yi W
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):591-3. PubMed ID: 15151844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J; Kubinyi J; Telička Z
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
    Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P
    J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
    Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
    Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism].
    Mihailović J; Malesević M; Stefanović L; Krkljus D
    Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of large multinodular goitre using repeated doses of radioiodine.
    Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
    Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the factors responsible for over or under dose of 131 I therapy patients of hyperthyroidism.
    Muhammad W; Faaruq S; Hussain A; Kakakhail MB; Fatmi S; Matiullah
    Radiat Prot Dosimetry; 2008; 128(1):90-7. PubMed ID: 17533161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.